Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9DH2

Structure of Fab in complex with NKG2D extracellular domain

9DH2 の概要
エントリーDOI10.2210/pdb9dh2/pdb
分子名称Fab heavy chain, Fab light chain, NKG2-D type II integral membrane protein (3 entities in total)
機能のキーワードagonist, fab, receptor, immune system
由来する生物種Homo sapiens
詳細
タンパク質・核酸の鎖数12
化学式量合計251581.48
構造登録者
Fallon, D.,Huang, C.S. (登録日: 2024-09-03, 公開日: 2024-12-04, 最終更新日: 2024-12-18)
主引用文献Fallon, D.,Huang, C.S.,Ma, J.,Morgan, C.,Zhou, Z.S.
Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands.
Mabs, 16:2433121-2433121, 2024
Cited by
PubMed Abstract: Natural killer (NK) cells are effector cells of the innate immune system that distinguish between healthy and abnormal cells through activating and inhibitory receptor signaling. NKG2D, a homodimeric activating receptor expressed on NK cells, recognizes a diverse class of stress ligands expressed by cells experiencing infection, malignant transformation, chronic inflammation, and other cellular stresses. Despite the variety of NKG2D ligands, they all bind the receptor asymmetrically in a 1:1 ligand to homodimeric NKG2D stoichiometry. In contrast, as we report herein, the agonistic antibody 2D3 binds NKG2D with a 2:1 stoichiometry of its antigen binding fragments to homodimeric NKG2D and a largely distinct epitope. This binding interaction, as compared to NKG2D natural ligands, suggests there may be unique mechanisms to engage this receptor while offering possible benefits when incorporated into an IgG-based therapeutic.
PubMed: 39582357
DOI: 10.1080/19420862.2024.2433121
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.98 Å)
構造検証レポート
Validation report summary of 9dh2
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon